The renaissance of drug delivery systems for the posterior segment

Retina Today

Volumn , Issue OCTOBER, 2011, Pages 22-25

  Shapiro, Aron ^a   Lazar, Eliot ^b  

^a Retina at Ora Inc   (United States)

^b ElCon Medical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82555185076     PISSN: None     EISSN: 18250572     Source Type: Journal    
DOI: None     Document Type: Note

References (18)

1. Worakul N, Unlu N, Robinson JR. Ocular Pharmacokinetics. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Vol 1. 2nd ed. Philadelphia: W.B. Saunders Company; 2000:202-211.
2. Vitrasert (ganciclovir intravitreal implant) 4.5 mg [package insert]. Available at: http://www.bausch.co.uk/en_US/ecp/pharma/product/vitrasert.aspx.
3. Retisert (fluocinolone acetonide intravitreal implant) 0.59 mg [package insert]. Available at: http://www.bausch.com/en/ECP/Our-Products/Rx-Pharmaceuticals/Rx-Pharmace uticals-ECP/Retisert.
4. Ozurdex [package insert]. Irvine, CA; Allergan; 2010. 2010.
5. Iluvien for diabetic macular edema (DME) [package insert]. Available at: http://www.alimerasciences.com/Products/iluvien.aspx.
6. NT-501. http://www.neurotechusa.com/ect/nt-501.asp. Accessed September 22, 2011.
7. Zhang K, Hopkins JJ, Heier JS, et al. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci U S A. 2011;108(15):6241-6245.
8. Hydrogel drug delivery systems. Available at: http://www.ocutx.com/pipeline/drug-delivery/ technology#ppd.
9. Ocular Therapeutix, Inc. completes series D financing to support phase II sustained drug delivery clinical trials. Available at: http://www.ocutx.com/images/stories/otx_series_d_press_release.pdf.
10. Atrigel / PDT / punctal plug delivery system. Available at: http://www.qltinc.com/development/ technologies/punctalPlugDelivery.htm.
11. A study of the L-PPDS with adjunctive Xalatan eye drops in subjects with OH or OAG. Available at: http://clinicaltrials.gov/ct2/show/NCT01037036?term=QLT+Plug+Delivery &rank=2. Accessed September 27, 2011.
12. The ODTx solution: a revolutionary breakthrough in ophthalmic drug delivery. Available at: http://ondemandtx.com/the-odtx-solution.aspx. Accessed September 22, 2011.
13. Replenish, Inc: product description and device development. Available at: http://www.replenishinc.com/our-technology/product-description.
14. Jiang J, Moore JS, Edelhauser HF, Prausnitz MR. Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res. 2009;26(2):395-403.
15. Jiang J, Gill HS, Ghate D, et al. Coated microneedles for drug delivery to the eye. Invest Ophthalmol Vis Sci. 2007;48(9):4038-4043.
16. ProRetina Therapeutics. Available at: http://www.proretina.com/ingles/quienesomos.html.
17. Molokhia SA, Sant H, Simonis J, et al. The capsule drug device: novel approach for drug delivery to the eye. Vision Res. 2010;50(7):680-685.
18. SurModics enters ophthalmic license and development agreement with Roche and Genentech. Available at: http://phx.corporate-ir.net/phoenix.zhtml?c=80353&p=irolnewsArticle &ID=1339001.